1. "Radiation Oncology, Department of"
  2. "Carol Portlock"
Formats
  1. Journal Article (26)
  2. Meeting Abstract (23)
  3. Book Section (6)
Groups
  1. Center for Hematologic Malignancies (55)
  2. Department of Medicine (55)
  3. Hematologic Malignancies, Division of (55)
  4. Lymphoma (55)
  5. Radiation Oncology, Department of (55)
  6. Survivorship Research (55)

More Groups

People
  1. Carol Portlock (55)
  2. Joachim Yahalom (55)
  3. David Straus (36)
  4. Andrew Zelenetz (35)
  5. Craig Moskowitz (34)
  6. Ariela Noy (30)

More People

Years
  1. 2021 (1)
  2. 2017 (3)
  3. 2016 (2)
  4. 2015 (4)
  5. 2014 (1)
  6. 2013 (1)

More Years

Publications
  1. Blood (22)
  2. Journal of Clinical Oncology (6)
  3. British Journal of Haematology (3)
  4. International Journal of Radiation Oncology, Biology, Physics (3)
  5. Annals of Oncology (2)
  6. Haematologica (2)

More Publications

Publishers
  1. American Society of Hematology (23)
  2. American Society of Clinical Oncology (6)
  3. Elsevier Inc. (5)
  4. Lippincott Williams & Wilkins (5)
  5. John Wiley & Sons (3)
  6. Ferrata Storti Foundation (2)

More Publishers

Results (55)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Involved-site radiotherapy for Helicobacter pylori-independent gastric MALT lymphoma: 26 years of experience with 178 patients
    Journal Article

    Yahalom, J.; Xu, A. J.; Noy, A.; Lobaugh, S.; Chelius, M.; Chau, K.; Portlock, C.; Hajj, C.; Imber, B. S.; Straus, D. J.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • A pilot study of brentuximab vedotin and AVD chemotherapy followed by 20 Gy involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma
    Meeting Abstract

    Kumar, A.; Casulo, C.; Advani, R. H.; Budde, L.; Barr, P. M.; Batlevi, C. L.; Caron, P.; Chen, R. W.; Constine, L. S.; Courtien, A.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma
    Journal Article

    Moskowitz, A. J.; Schöder, H.; Gavane, S.; Thoren, K. L.; Fleisher, M.; Yahalom, J.; McCall, S. J.; Cadzin, B. R.; Fox, S. Y.; Gerecitano, J.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Baseline metabolic tumor volume is an independent prognostic factor for relapsed and refractory Hodgkin lymphoma patients receiving PET-adapted salvage therapy with brentuximab vedotin and augmented ICE
    Meeting Abstract

    Moskowitz, A. J.; Schöder, H.; Gavane, S.; Thoren, K. L.; Fleisher, M.; Yahalom, J.; McCall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • PET-adapted therapy with brentuximab vedotin and augmented ICE for relapsed/refractory Hodgkin lymphoma - Lack of Improvement with 3 versus 2 cycles of weekly brentuximab vedotin
    Meeting Abstract

    Moskowitz, A. J.; Schöder, H.; Yahalom, J.; McCall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; Hamlin, P. A.; Horwitz, S.; Kobos, R.; more...
    Haematologica (2016)

    Fulltext@MSK | Save
  • Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma
    Journal Article

    Kumar, A.; Casulo, C.; Yahalom, J.; Schöder, H.; Barr, P. M.; Caron, P.; Chiu, A.; Constine, L. S.; Drullinsky, P.; Friedberg, J. W.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Long-term outcome of 490 patients with early-stage extra-nodal marginal zone lymphoma
    Meeting Abstract

    Yahalom, J.; Teckie, S.; Qi, S.; Hsu, M.; Lovie, S.; Chelius, M.; Noy, A.; Portlock, C.
    Haematologica (2015)

    Fulltext@MSK | Save
  • Very low utility of surveillance imaging in early-stage classic Hodgkin lymphoma treated with a combination of doxorubicin, bleomycin, vinblastine, and dacarbazine and radiation therapy
    Journal Article

    Gandikota, N.; Hartridge-Lambert, S.; Migliacci, J. C.; Yahalom, J.; Portlock, C. S.; Schöder, H.
    Cancer (2015)

    Fulltext@MSK | Save
  • Long-term outcomes and patterns of relapse of early-stage extranodal marginal zone lymphoma treated with radiation therapy with curative intent
    Journal Article

    Teckie, S.; Qi, S.; Lovie, S.; Navarrett, S.; Hsu, M.; Noy, A.; Portlock, C.; Yahalom, J.
    International Journal of Radiation Oncology, Biology, Physics (2015)

    Fulltext@MSK | Save
  • PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: A non-randomised, open-label, single-centre, phase 2 study
    Journal Article

    Moskowitz, A. J.; Schöder, H.; Yahalom, J.; Mccall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; Hamlin, P. A.; Horwitz, S.; Kobos, R.; more...
    Lancet Oncology (2015)

    Fulltext@MSK | Save